Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities-Reference-Cited by-同舟云学术

Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities

Published:2011-09-09 Issue:3 Volume:26 Page:550-554
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Vicente C,Vazquez I,Conchillo A,García-Sánchez M A,Marcotegui N,Fuster O,González M,Calasanz M J,Lahortiga I,Odero M D

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2011235.pdf

Reference11 articles.

1. Tsai FY, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994; 371: 221–226.

2. Huang Z, Dore LC, Li Z, Orkin SH, Feng G, Lin S et al. GATA-2 reinforces megakaryocyte development in the absence of GATA-1. Mol Cell Biol 2009; 29: 5168–5180.

3. Fadilah SA, Cheong SK, Roslan H, Rozie-Hanisa M, Yen GK . GATA-1 and GATA-2 gene expression is related to the severity of dysplasia in myelodysplastic syndrome. Leukemia 2002; 16: 1563–1565.

4. Shimamoto T, Ohyashiki K, Ohyashiki JH, Kawakubo K, Fujimura T, Iwama H et al. The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia. Blood 1995; 86: 3173–3180.

5. Ayala RM, Martinez-Lopez J, Albizua E, Diez A, Gilsanz F . Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia. Am J Hematol 2009; 84: 79–86.

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impaired DNA damage response and inflammatory signalling underpins hematopoietic stem cell defects inGata2haploinsufficiency;2024-08-21

2. Influence of genetic co‐mutation on chemotherapeutic outcome in NPM1‐mutated and FLT3‐ITD wild‐type AML patients;Cancer Medicine;2024-08

3. Prognostic significance of GATA2 in patients with MDS/AML: a systematic review and meta-analysis;Annals of Hematology;2024-07-19

4. Single-cell analysis of pediatric acute myeloid leukemia samples uncovers treatment-resistant stem and mast cells;2024-07-10

5. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia;Blood Advances;2023-12-28